Triple-A syndrome: Difference between revisions
No edit summary |
CSV import |
||
| Line 1: | Line 1: | ||
{{ | {{Short description|A rare autosomal recessive disorder}} | ||
| | {{Use dmy dates|date=October 2023}} | ||
}} | |||
'''Triple-A syndrome''' | '''Triple-A syndrome''', also known as '''Allgrove syndrome''', is a rare [[autosomal recessive]] disorder characterized by the triad of [[achalasia]], [[Addison's disease]], and [[alacrima]]. It is caused by mutations in the AAAS gene, which encodes the protein ALADIN, involved in nuclear pore complex function. | ||
== | ==Signs and symptoms== | ||
The hallmark features of Triple-A syndrome include: | |||
* '''Achalasia''': A condition where the lower esophageal sphincter fails to relax properly, leading to difficulty swallowing (dysphagia), regurgitation, and sometimes chest pain. | |||
* '''Addison's disease''': A disorder of the [[adrenal glands]] leading to insufficient production of [[cortisol]] and [[aldosterone]], resulting in symptoms such as fatigue, muscle weakness, weight loss, low blood pressure, and hyperpigmentation. | |||
* '''Alacrima''': A lack of tear production, which can lead to dry eyes and increased risk of eye infections. | |||
Other symptoms may include [[neurological]] abnormalities, such as [[autonomic dysfunction]], [[peripheral neuropathy]], and [[cognitive impairment]]. | |||
== | ==Genetics== | ||
Triple-A syndrome is inherited in an [[autosomal recessive]] pattern, meaning that both copies of the gene in each cell have mutations. The AAAS gene is located on chromosome 12q13. Mutations in this gene disrupt the function of the ALADIN protein, affecting the nuclear pore complex and leading to the symptoms of the syndrome. | |||
Triple-A syndrome is | ==Diagnosis== | ||
Diagnosis of Triple-A syndrome is based on clinical evaluation, family history, and genetic testing to identify mutations in the AAAS gene. Additional tests may include esophageal manometry for achalasia, ACTH stimulation test for adrenal insufficiency, and Schirmer's test for alacrima. | |||
==Management== | |||
Management of Triple-A syndrome is symptomatic and supportive. Treatment may include: | |||
* For achalasia: [[Pneumatic dilation]], [[Heller myotomy]], or [[botulinum toxin]] injections. | |||
* For Addison's disease: Lifelong hormone replacement therapy with glucocorticoids and mineralocorticoids. | |||
* For alacrima: Artificial tears and other measures to protect the eyes. | |||
Regular monitoring and multidisciplinary care are essential to address the various aspects of the syndrome. | |||
== | ==Prognosis== | ||
The prognosis for individuals with Triple-A syndrome varies depending on the severity of symptoms and the effectiveness of treatment. With appropriate management, many individuals can lead relatively normal lives, although they may require ongoing medical care. | |||
==Related pages== | |||
* [[Achalasia]] | |||
* [[Addison's disease]] | |||
* [[Alacrima]] | |||
* [[Autosomal recessive disorder]] | |||
== | ==References== | ||
{{Reflist}} | |||
==External links== | |||
* [https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&Expert=271 Orphanet: Triple A syndrome] | |||
* [ | |||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
[[Category:Syndromes]] | [[Category:Syndromes]] | ||
[[File:1471-2415-4-7-1-l.jpg|thumb|right|Image related to Triple-A syndrome]] | |||
Revision as of 15:47, 9 February 2025
A rare autosomal recessive disorder
Triple-A syndrome, also known as Allgrove syndrome, is a rare autosomal recessive disorder characterized by the triad of achalasia, Addison's disease, and alacrima. It is caused by mutations in the AAAS gene, which encodes the protein ALADIN, involved in nuclear pore complex function.
Signs and symptoms
The hallmark features of Triple-A syndrome include:
- Achalasia: A condition where the lower esophageal sphincter fails to relax properly, leading to difficulty swallowing (dysphagia), regurgitation, and sometimes chest pain.
- Addison's disease: A disorder of the adrenal glands leading to insufficient production of cortisol and aldosterone, resulting in symptoms such as fatigue, muscle weakness, weight loss, low blood pressure, and hyperpigmentation.
- Alacrima: A lack of tear production, which can lead to dry eyes and increased risk of eye infections.
Other symptoms may include neurological abnormalities, such as autonomic dysfunction, peripheral neuropathy, and cognitive impairment.
Genetics
Triple-A syndrome is inherited in an autosomal recessive pattern, meaning that both copies of the gene in each cell have mutations. The AAAS gene is located on chromosome 12q13. Mutations in this gene disrupt the function of the ALADIN protein, affecting the nuclear pore complex and leading to the symptoms of the syndrome.
Diagnosis
Diagnosis of Triple-A syndrome is based on clinical evaluation, family history, and genetic testing to identify mutations in the AAAS gene. Additional tests may include esophageal manometry for achalasia, ACTH stimulation test for adrenal insufficiency, and Schirmer's test for alacrima.
Management
Management of Triple-A syndrome is symptomatic and supportive. Treatment may include:
- For achalasia: Pneumatic dilation, Heller myotomy, or botulinum toxin injections.
- For Addison's disease: Lifelong hormone replacement therapy with glucocorticoids and mineralocorticoids.
- For alacrima: Artificial tears and other measures to protect the eyes.
Regular monitoring and multidisciplinary care are essential to address the various aspects of the syndrome.
Prognosis
The prognosis for individuals with Triple-A syndrome varies depending on the severity of symptoms and the effectiveness of treatment. With appropriate management, many individuals can lead relatively normal lives, although they may require ongoing medical care.
Related pages
References
<references group="" responsive="1"></references>
External links
